Sanofi links with Evotec to tap stem cells for diabetes care – Reuters

ReutersSanofi links with Evotec to tap stem cells for diabetes careReutersFrench drugmaker Sanofi is linking with Evotec to develop stem cell-based treatments for diabetes, under a deal that could earn the German biotech firm more than 300 million euro...
http://blog.zandcell.com/sanofi-links-with-evotec-to-tap-stem-cells-for-diabetes-care-reuters/